SCHEMBL30474540

SCHEMBL30474540

COC(=O)CCN[C@H]1CCNC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.50
▸ EPHX2 P34913 3/20 0.43
▸ DPP4 P27487 1/20 0.42
▸ FAP Q12884 1/20 0.42
▸ DPP8 Q6V1X1 1/20 0.42
▸ DPP9 Q86TI2 1/20 0.42
▸ TSHR P16473 2/20 0.39
▸ CA12 O43570 1/20 0.38
▸ CA14 Q9ULX7 1/20 0.38
▸ GNAI3 P08754 3/20 0.37
▸ GNAO1 P09471 3/20 0.37
▸ GNAI1 P63096 3/20 0.37
▸ EPHX1 P07099 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ VCP P55072 1/20 0.35
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ DRD4 P21917 1/20 0.34
▸ KDM1A O60341 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19485629 0.90 GNAI3 (0.46) KCNH2EPHX2TSHRCA12CA14
SCHEMBL30474564 0.86 KCNH2 (0.50) KCNH2EPHX2DPP4FAPDPP8
SCHEMBL31370238 0.81 KCNH2 (0.50) KCNH2DPP4FAPDPP8DPP9
SCHEMBL9805865 0.80 EPHX2 (0.51) EPHX2TSHRCA12CA14VCP
Hydrochloric Acid SCHEMBL7295649 0.78 EPHX2 (0.50) EPHX2TSHRCA12CA14VCP
Tert-Butyl Formate SCHEMBL27790899 0.77 GNAI3 (0.36) EPHX2TSHRCA12CA14GNAI3
SCHEMBL6972472 0.77 EPHX2 (0.57) EPHX2TSHRCA12CA14VCP
SCHEMBL619500 0.77 EPHX2 (0.62) EPHX2TSHRCA12CA14
SCHEMBL12120518 0.75 KCNH2 (0.49) KCNH2DPP4FAPDPP8DPP9
SCHEMBL1202915 0.75 EPHX2 (0.65) EPHX2TSHRCA12CA14EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113354635-B Pyrrolidine integrin regulator and application thereof 清药同创(北京)药物研发中心有限公司 2023-04-18 — — CN disclosed
Send feedback